Pharmaceutical Executive Digital Edition - July 2011
Pedal to the Mettle
What the 2011 Census of India Reveals for Pharma
What India's latest census tells us about current and future pharma opportunities.
Holy Surge of Enthusiasm!
While Europe's EFPIA preaches about embracing change, much remains to be done to prove the adjustment in philosophy
10 Emergency Brand Building Questions
EAB Member Al Topin delivers 10 questions that should drive your brand-building marketing program.
New Ways to Gain New Brand Insights
If you can learn to understand patient and physician behavior, you are well on your way to strengthening the position of your product
Poland: A Sleeping Giant
A country that bridges East and West, old and new-while boasting a growing economy in Europe-is being looked to for its pool of talented industry resources
Battles over Biosimilars
Sponsors must handle interchangeability, exclusivity, cost and coverage hurdles to win biosimilars game
Planning Beyond the Petri Dish
Pfizer's crizotinib development program combined organization, art, and science-and a large dose of unforeseen risk
Truth Found in the Wrong Places
More bad ideas on how to manage the healthcare burden are circulating beyond the stakeholders that initiated them
Cancer: From Rut to Racetrack
The objective is to make most cancers a curable, chronic condition. But with soaring costs, crowded therapeutic competition, and new diagnostic reimbursement challenges ahead, can industry deliver?
How to Prevent a Facebook Faux Pas
'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.
Precious Mettle
Taking Onyx Pharmaceuticals to new heights – CEO Tony Coles talks to PharmExec about the midsize company's transition from adolescence to adulthood.
